Immunoengineering
Kristopher White
Postdoctoral Scholar
University of California - Irvine
Irvine, California, United States
Victor Pozzo
Research Fellow
Massachusetts General Hospital, United States
Alec Andrews
Senior Research Technologist
Massachussetts General Hospital, United States
Pierre Tawa
Research Fellow
Massachusetts General Hospital, United States
Golda Romano
Research Fellow
Massachusetts General Hospital, United States
Alexandre G. Lellouch
Assistant Investigator
Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Shriners Children's Hospitals, Boston, USA; Groupe Almaviva Santè, Clinique de I’Alma, Paris, France, United States
Curtis L. Centrulo Jr.
Attending Surgeon and Assistant Professor
Massachusetts General Hospital, Harvard Medical School, and Shriners Children's Hospitals, Boston, USA, United States
Ronke Olabisi
Associate Professor
University of California, Irvine, United States
Visually, we observed no scab formation in HEMIs treatments and scarring was soft, flat, and non-adherent (Figure 1A). Exudate was clearly visible early in hydrogel-treated wounds. However, this exudate subsided over time and was not determined to be infectious. The exudate volume was also lower after removal of the treatment and replacement of the Tegaderm at week 2. All wounds treated with coencapsulated MSCs and ISCs closed faster than standard-of-care wounds (Figure 1B). Visually, hematoxylin and eosin-stained tissue biopsies show epidermal, dermal, and hypodermal layer formation (Figure 2). The hypodermal layer did not develop in control or MSC-only groups. At 5 weeks post-escharotomy, development and restratification of the epidermis and dermis was observed at the edges of wounds treated with dual cell hydrogels. Our results indicate that co-encapsulation of MSCs and ISCs accelerates wound healing in a porcine burn model, demonstrating increased regenerative capabilities in skin similar in structure to that of human skin.
SCRNA-seq and gene ontology analysis revealed that all differentially expressed genes in MSCs treated with insulin when compared against untreated control MSCs are also known to be involved in wound healing (Figure 3). Sequencing studies are ongoing to further probe how insulin and insulin-secreting cells affect MSC gene expression in juxtacrine and paracrine environments relevant to wound healing.
Taken together, these observations suggest that presence of insulin primes the MSCs to promote skin regeneration through immunomodulatory and wound healing pathways.